Month: November 2024
-
CSL, Sanofi on Moderna funding deal
- 27 Nov 2024
Global Head of Operations calls for ‘open consultative process involving all stakeholders’ to examine implications of the Moderna deal.
Read more -
Post-PBAC processing too slow, say sponsors
- 27 Nov 2024
Companies call Health out on speed of PBS listings, BioMarin’s MD saying the current expectation of six months ‘is a farce’.
Read more -
Organon leaves Pill Hill for Art Deco digs
- 27 Nov 2024
The MSD spinoff departs its original space in Talavera Road, Macquarie Park, and settles into its new home in the heart of Sydney’s CBD.
Read more -
Roche outlays up to $2.3B for off-the-shelf CAR Ts
- 27 Nov 2024
Acquiring Poseida Therapeutics and its off-the-shelf CAR T pipeline for solid tumours and autoimmune conditions, and its genetic engineering platform.
Read more -
The Aussie pharmas with a gender problem
- 25 Nov 2024
Aussie pharma is a dominated by women but seven companies have a significant gender imbalance. Despite this, only one has set targets to correct it.
Read more -
Jobs market moves in employers’ favour
- 25 Nov 2024
‘Cautious optimism’ replaces uncertainty in the life sciences jobs market, with employees receiving modest pay rises and most still willing to move for money.
Read more -
Moderna deal sparks ‘level playing field’ concerns
- 25 Nov 2024
Government deal allowing Moderna products to be funded outside the NIP prompts Medicines Australia and top vaccine expert to flag potential problems.
Read more -
Health wins control of Quality Use of Medicines
- 25 Nov 2024
NPS MedicineWise shut down following a dispute with Health, and now the Dept has picked up $34.4 million a year to do the job itself.
Read more








